<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>72a331f7-5068-41b5-ad16-fab842e76fce</id>
  <name>VTE Prophylaxis-COVID-19, Adult Order Panel</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~72a331f7-5068-41b5-ad16-fab842e76fce~NAME~VTE Prophylaxis-COVID-19, Adult Order Panel}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Admitted patients with COVID-19 selected for prophylactic dosing should receive tinzaparin as close as possible to 75 units/kg. Additional dose bands (6,000 units of tinzaparin per day for persons weighing 80-90 kg and 7,000 units for persons weighing 90-100 kg) have been added to facilitate this.&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;-Guidance: Antithrombotics in Adult Patients with COVID-19&lt;/strong&gt;&lt;br&gt;https://manual.connect-care.ca/home/hot-topics/covid-19/covid-19-decision-supports/covid-19-adult-admission-orderset#h.zf2eo0utgp0s&lt;/p&gt;&lt;p&gt;&lt;br&gt;&lt;strong&gt;- Score: HAS-BLED&lt;/strong&gt;&lt;br&gt;https://ahsweb.ca/HEE/MD_Calc_HAS-BLED_score&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Clinical Decision Support&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;u&gt;&lt;strong&gt;Recommendation:&lt;/strong&gt;&lt;/u&gt; Identify the risk factors below and select the appropriate therapy based on the patient’s risk for developing VTE.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;table cellpadding=&quot;1&quot; cellspacing=&quot;1&quot; border=&quot;1&quot; style=&quot;width:500px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&amp;nbsp;Low Risk&lt;/td&gt;&lt;td&gt;&amp;nbsp;No Risk Factors&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&amp;nbsp;Moderate Risk&lt;/td&gt;&lt;td&gt;&amp;nbsp;1 or 2 Minor Risk Factors&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&amp;nbsp;High Risk&lt;/td&gt;&lt;td&gt;&amp;nbsp;1 Major Risk Factor OR 3 to 4 Minor Risk Factors&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&amp;nbsp;Very High Risk&lt;/td&gt;&lt;td&gt;&amp;nbsp;Trauma; More than 1 Major Risk Factor +/- Multiple Minor Risk Factors&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&lt;br&gt;&lt;u&gt;Major Risk Factors: &lt;/u&gt;Major surgery, trauma, ischemic stroke or paralysis, spinal cord injury, previous VTE, congenital and/or acquired thrombophilia states, or active cancer and its treatment, active COVID-19 infection&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;u&gt;Minor Risk Factors:&lt;/u&gt; Age greater than 40 years, estrogen therapy, nephrotic syndrome, pregnancy/postpartum, prolonged immobility greater than 24 hours, general anesthesia longer than 1 hour, severe respiratory disease, collagen vascular disease, inflammatory bowel disease, congestive heart failure, obesity, sepsis, varicose veins&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;u&gt;&lt;strong&gt;Contraindications:&lt;/strong&gt;&lt;/u&gt;&lt;br&gt;Uncontrolled hypertension, Bleeding disorders (platelets less than 50 x 109/L), Recent intracranial or intraocular hemorrhage, Lumbar puncture within 24 hours, Active bleeding, Heparin-induced thrombocytopenia (HIT)&lt;br&gt;For patients on heparins, certain drugs can enhance bleeding tendency: acetylsalicylic acid (ASA) and other antiplatelet agents (e.g. clopidogrel, ticagrelor), and nonsteroidal anti-inflammatory drugs (NSAIDs) (particularly ketorolac). This is particularly relevant for patients with intrathecal catheters for analgesia where low molecular weight heparin (LMWH) or unfractionated heparin(UFH ) must NOT be used in conjunction with antiplatelet agents.&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;u&gt;&lt;strong&gt;Warning: &lt;/strong&gt;&lt;/u&gt;This is particularly relevant for patients with INTRATHECAL catheters for analgesia where UFH or LMWH must NOT be used in conjunction with antiplatelet agents.&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;u&gt;&lt;strong&gt;Dose Adjustment:&lt;/strong&gt;&lt;/u&gt; Consider adjusting dosage for extremes of weight and renal dysfunction. Adjusted Dosing orders are available in this order set.&amp;nbsp;&lt;br&gt;&amp;nbsp;&lt;br&gt;In order to avoid the higher risk of heparin-induced thrombocytopenia, use of unfractionated heparin should be minimized.&amp;nbsp;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Highest Risk&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Select tinzaparin AND consider ONE additional therapy order&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Highest Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Highest Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Highest Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;&lt;strong&gt;Weight-Band Dosing for Subcutaneous Tinzaparin&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;u&gt;No Weight Documented&lt;/u&gt;:&amp;nbsp;Please close this order and enter a weight on this patient so that the correct dosage will populate. &amp;nbsp;Alternatively, use the dosing chart to determine the appropriate dose.&lt;/p&gt;&lt;p&gt;&lt;u&gt;Weight Documented&lt;/u&gt;: The system will choose the appropriate weight based on the table below.&lt;/p&gt;&lt;table cellpadding=&quot;1&quot; cellspacing=&quot;1&quot; border=&quot;1&quot; style=&quot;width:670px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Weight Band &lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patient Actual Body Weight (kg)&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;&lt;strong&gt;Tinzaparin Dosing&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;Less than 30 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;2500 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;30 to 39.9 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;3500 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;40 to 80 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;4500 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;80.1 to 90 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;6000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;90.1 to 100 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;7000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;100.1 to 120 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;8000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;120.1 to 150 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;10,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;150.1 to 175 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;12,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;175.1 to 200 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;14,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;200.1 to 250 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;16,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;Greater than 250 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;75 units/kg SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Highest Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tinzaparin injection;4500 unit/0.45 mL injection syringe (adjust for weight less than 40 kg)&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp; Adjust for weight less than 40 kg;&lt;/p&gt;&lt;p&gt;4,500 Units, subcutaneous, daily, at bedtime, Continue until discharge&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;heparin injection for bolus - units, units/kg/dose; 5000 unit/0.5 mL injection (IF eGFR +/- Creatinine Clearance LESS than 20 mL/minute)&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp; IF eGFR +/- Creatinine Clearance LESS than 20 mL/minute;&lt;/p&gt;&lt;p&gt;5,000 Units, subcutaneous, every 12 hours, Continue until discharge&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations Routine&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations Repeating&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;To monitor platelet count for heparin-induced thrombocytopenia (HIT) in heparin-exposed patients with risk of HIT greater than 1%.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations Repeating&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication; Avoid intramuscular (IM) injections while receiving anticoagulant therapy&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication; Hold VTE prophylaxis if platelets 50 x 10^9 /L or less.&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="VTE Prophylaxis-COVID-19, Adult Order Panel">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #1"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Clinical Decision Support">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Treatment Options">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Contraindication to Anticoagulation">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="NURINT Sequential Compression Device [NUR536] IP Order" max="1" path="/items" name="Sequential Compression Device; Until discontinued"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Medications">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Highest Risk">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; subcutaneous, daily, at bedtime, First Dose today at 2100"/>
            </Item>
          </Item>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="NURINT Sequential Compression Device [NUR536] IP Order" max="1" path="/items" name="Sequential Compression Device; until discontinued"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df94fc61-7e8a-4890-8269-d3cea3b1064f" concept_name="NURINT AntiEmbolism Stockings [NUR560] IP Order" max="1" path="/items" name="AntiEmbolism Stockings; Until discontinued, Recommended for highest risk patients as additional therapy. Not preferred with ischemic stroke"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Renal Dysfunction Dosing">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection;4500 unit/0.45 mL injection syringe (adjust for weight less than 40 kg)"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin injection for bolus - units, units/kg/dose; 5000 unit/0.5 mL injection (IF eGFR +/- Creatinine Clearance LESS than 20 mL/minute)"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laboratory Investigations Routine">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d58f0c7d-30da-4d27-a82a-b42c8fae7c23" concept_name="LAB CBC No Differential [LAB294] Order" max="1" path="/items" name="CBC, No Differential; Once, To provide baseline platelet count for patients receiving heparin"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laboratory Investigations Repeating">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d58f0c7d-30da-4d27-a82a-b42c8fae7c23" concept_name="LAB CBC No Differential [LAB294] Order" max="1" path="/items" name="CBC, No Differential; Every 3 days, for 5 occurrences"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="NURCOM Nursing Communication [NUR193] IP Order" max="1" path="/items" name="Nursing Communication; Avoid intramuscular (IM) injections while receiving anticoagulant therapy"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="NURCOM Nursing Communication [NUR193] IP Order" max="1" path="/items" name="Nursing Communication; Hold VTE prophylaxis if platelets 50 x 10^9 /L or less."/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e79ae6f-5402-4d96-b79f-68e943d8a4d2" concept_name="NURCOM Notify Most Responsible Health Practitioner (MRHP) [NUR183] IP Order" max="1" path="/items" name="Notify Most Responsible Health Practitioner (MRHP); Notify to reassess prophylaxis, if platelets 100 x 10^9 /L or less."/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.orderable_section.v1">
    <digest id="MD5-CAM-1.0.1">A89AC74BC8CAD3F0719579389C69006F</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.booleanorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">56B5A2F2979B94F83C97E66B46679692</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.quantityorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">22AFA84E6D7935A3623EDFA7C2EB6D65</digest>
  </integrity_checks>
</template>